| 注册
首页|期刊导航|重庆医学|叶酸联合甲钴胺对脑小血管病合并高同型半胱氨酸血症患者认知功能的影响

叶酸联合甲钴胺对脑小血管病合并高同型半胱氨酸血症患者认知功能的影响

傅朝晖 吴娟 陈登容

重庆医学Issue(9):1055-1057,3.
重庆医学Issue(9):1055-1057,3.DOI:10.3969/j.issn.1671-8348.2014.09.011

叶酸联合甲钴胺对脑小血管病合并高同型半胱氨酸血症患者认知功能的影响

The efficacy of folic acid combined with mecobalamine for the treatment of mild cognitive impairment in patients with cerebral small vessel disease and hyperhomocysteinemia

傅朝晖 1吴娟 1陈登容1

作者信息

  • 1. 重庆市第三人民医院老年科 400014
  • 折叠

摘要

Abstract

Objective To observe the efficacy of folic acid combined with mecobalamine for the treatment of vascular mild cogni-tive impairment (VMCI) in patients with cerebral small vessel disease (SVD) and hyperhomocysteinemia(Hcy) .Methods A total of 84 VMCI patients with cerebral small vessel disease and Hcy were randomly divided into combination group and control group . Two groups received conventional therapy for 6 months .Besides ,the combination group received folic acid combined with mecobal-amin .The level of plasma Hcy and ADAS-cog score were observed before and after 3 months and 6 months treatment .Results Af-ter treatment ,plasma Hcy significantly lower in the combination group (P<0 .01) ,whereas it did not show any improvement in the control group .ADAS-cog scores in combination group decreased compared with that of before treatment ,but there was no statisti-cally significant difference after 3 months treatment(P>0 .05) .However ,after 6 months treatment ,the ADAS-cog scores decreased obviously than that in the before treatment group (P<0 .05) .ADAS-cog scores in control group increased compared with before treatment ,but there was no statistically significant difference in after treatment (P>0 .05) .After 3 months treatment ,there was no significant difference on ADAS-cog score between combination group and control group (P>0 .05) ,however ,there had significant difference between the two groups after 6 months treatment(P<0 .05) .Conclusion The level of plasma Hcy could be reduced by adding folic acid and mecobalamin .Treatment of hyperhomocysteinemia may delay the progression of vascular cognitive impairment w hich caused by cerebral small vessel disease .

关键词

血管疾病/血管性轻度认知损害/高同型半胱氨酸/叶酸/甲钴胺

Key words

vascular diseases/vascular mild cognitive impairment/hyperhomocysteine/folic acid/mecobalamin

引用本文复制引用

傅朝晖,吴娟,陈登容..叶酸联合甲钴胺对脑小血管病合并高同型半胱氨酸血症患者认知功能的影响[J].重庆医学,2014,(9):1055-1057,3.

基金项目

重庆市卫生局科技计划项目(2012-2-222)。 ()

重庆医学

OA北大核心CSTPCD

1671-8348

访问量0
|
下载量0
段落导航相关论文